Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 7, 2020; 26(29): 4343-4355
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4343
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4343
Table 4 Extent of discussing with own physician the effect of smoking on inflammatory bowel diseases based on type of diagnosis
Questionnaire items | Crohn’s disease | Ulcerative colitis | P value1 |
Cigarette smoking | |||
Not discussed | 89/412 (21.6) | 143/321 (44.6) | < 0.001 |
Detrimental | 286/412 (69.4) | 47/321 (14.6) | |
Possibly beneficial | 37/412 (9.0) | 131/321 (40.8) | |
Use of alternative smoking products | |||
Not discussed | 43/83 (51.8) | 45/72 (62.5) | < 0.001 |
Detrimental | 31/83 (37.4) | 8/72 (11.1) | |
Possibly beneficial | 9/83 (10.8) | 19/72 (26.4) |
- Citation: Le Berre C, Loy L, Lönnfors S, Avedano L, Piovani D. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations. World J Gastroenterol 2020; 26(29): 4343-4355
- URL: https://www.wjgnet.com/1007-9327/full/v26/i29/4343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i29.4343